Newron Pharmaceuticals
NWRN.SW
#8290
Rank
A$0.27 B
Marketcap
$14.40
Share price
-0.74%
Change (1 day)
89.43%
Change (1 year)

Newron Pharmaceuticals (NWRN.SW) - Cash on Hand

Cash on Hand as of December 2023 : A$22.25 Million

According to Newron Pharmaceuticals's latest financial reports the company has A$22.25 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Newron Pharmaceuticals - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$20.44 M-43.05%
2022-12-31A$35.89 M-33.57%
2021-12-31A$54.03 M8.11%
2020-12-31A$49.98 M-20.22%
2019-12-31A$62.66 M-12.01%
2018-12-31A$71.21 M-22.88%
2017-12-31A$92.33 M36.18%
2016-12-31A$67.8 M10.38%
2015-12-31A$61.43 M60.84%
2014-12-31A$38.19 M33.89%
2013-12-31A$28.52 M-23.36%
2012-12-31A$37.22 M447.59%
2011-12-31A$6.79 M-35.81%
2010-12-31A$10.58 M-72.67%
2009-12-31A$38.74 M-52.62%
2008-12-31A$81.77 M-22.47%
2007-12-31A$0.10 B-15.72%
2006-12-31A$0.12 B343.08%
2005-12-31A$28.24 M